Usa Compression Partners LP stock hits 52-week high at 26.35 USD By Investing.com

USA Compression Partners LP (USAC) stock reached $26.35, though still below its all-time 52-week high of $30.1. The company has shown strong year-to-date gains of 17.01%, maintains a substantial 7.97% dividend yield, and recently completed an $860 million acquisition of J-W Power Company, expanding its operational capabilities. Despite an InvestingPro analysis suggesting slight overvaluation and overbought RSI, analysts like Mizuho and Texas Capital Securities have maintained price targets and ratings, citing positive natural gas macro trends.

Original reporting
Published Feb 10, 2026, 5:50 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Feb 10, 2026, 6:30 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$USAC
Bullish
medium confidence
Mentioned
$USAC
alphai data visualization · based on Investing.com South Africa
Decision brief

The 30-second read

$USACBullishMed
01

Why it matters

The company's recent acquisition and strong dividend yield bolster its growth prospects, potentially attracting income and growth-oriented investors.

02

Market read

The news is relevant to investors interested in energy infrastructure and natural gas markets, with potential implications for related stocks and sectors.

03

What to watch

Potential macroeconomic headwinds or sector-specific risks could impact the stock's performance despite positive news.

Timing: Immediate to short-term

Background

USA Compression Partners LP (USAC) operates in the energy infrastructure sector, providing compression services crucial for natural gas and oil transportation.

Company-level read

Ticker impact

$USACBullishMedium confidence
Context

The news highlights USA Compression Partners LP (USAC) reaching a 52-week high and recent strategic acquisitions, indicating positive momentum.

Expected impact

Moderate upward movement in the short to medium term, with potential for continued gains if macro trends persist.

Evidence & confidence

Fundamental factors such as acquisitions and dividend yield support bullish outlook, but technical overbought signals suggest caution.

Market effects

The energy infrastructure sector may experience increased investor interest due to strategic acquisitions and positive macro trends in natural gas.

Potential positive impact on regional energy markets, especially in areas where USAC operates.

Limited; primarily relevant to North American energy infrastructure investors.

Counterpoint

Some analysts suggest USAC may be overvalued due to technical overbought conditions, risking a short-term correction.

Key entities

  • USA Compression Partners LP

    A provider of natural gas compression services.

  • J-W Power Company

    A company specializing in compression and power generation services, acquired for $860 million.

Related articles

$USACMed

USA Compression Partners Q2 Earnings Call Highlights

USA Compression Partners (NYSE:USAC) reported Q2 metrics including 4.95 million total fleet horsepower, 92% utilization, and average revenue per revenue-generating horsepower per month of $22.84. Adjusted gross margin was 63.5% and leverage was 3.72x. The firm reaffirmed 2026 outlook for adjusted EBITDA $770m-$800m and distributable cash flow $480m-$510m, plus capex guidance.

$USACMed

USA Compression Partners, LP (USAC): Results of Operations and Financial Condition

USA Compression Partners, LP (USAC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 usacq22026ex991.htm EX-99.1 Document Exhibit 99.1 News Release USA Compression Partners, LP 8115 Preston Road, Suite 700 Dallas, Texas 75225 usacompression.com USA Compression Partners Reports Second-Quarter 2026 Results DALLAS, Texas, August 4, 2026 — USA Compression P

$ABUSMed

Could Arbutus Biopharma Corporation (ABUS) Turn its Moderna, Inc. (MRNA) Settlement Into a Lasting Biotech Advantage?

Arbutus Biopharma (ABUS) received about $178 million from Moderna (MRNA) as its share of a $950 million noncontingent LNP patent settlement, with reimbursement of legal costs and an expected Q3 dividend tied to Genevant. ABUS reported Q1 2026 revenue of $179.1 million and net income of $169.7 million. Moderna reported Q2 2026 revenue of $145 million and a net loss of $782 million, plus FDA approval for mFLUSIVA.

$IONQMedAI 8/10

Pentagon may see one of quantum computing’s first practical winners

IonQ (IONQ) said DARPA awarded a $28 million contract modification under its It’s About Time program to support production development and 25 Evergreen-05 optical atomic clocks, with a $30 million option for 100 additional clocks. IonQ plans to invest $15 million to scale manufacturing. The company cites timing performance for GPS-denied defense uses.

$CCEYFMedAI 8/10

CanCambria Energy Provides Updated Contingent Resource Evaluation for Flagship Deep Gas Project, Attributable to Strong European Natural Gas Prices, Driving an Increased NPV10 of US$2.04 Billion

CanCambria Energy Corp. (TSXV: CCEC) reported an updated independent contingent resource evaluation for its 100% owned Kiskunhalas deep gas project in southern Hungary. Prepared by CHPE (effective June 30, 2026), it assumes $12.00/MMBtu TTF1 gas. Risked 2C Development Pending NPV10 rose 16% to US$2.04B from US$1.762B; 2C volumes are 571.9 Bcf and 59.6 MMbbl. First gas is targeted for mid-2027.